#Centers for Disease Control and Prevention

“We must work to ensure individuals aren’t forced to choose between their treatment and their employment,” says ACS CAN’s president.

Risk-based testing alone has failed to identify a majority of people living with chronic HBV.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.

In September, the National Comprehensive Cancer Network (NCCN) released updated COVID vaccine recommendations.

Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.

The lack of a steady source of money from year to year is jeopardizing health department programs.

“It is clear e-cigarettes continue to play a major role in preventing our ability to achieve a tobacco-free generation.”

Pre-pandemic report shows a modest improvement for survival for people with hard-to-treat pancreatic cancer.

Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.

After mishandling COVID-19 and monkeypox, the Centers for Disease Control and Prevention aims to change—with help from Mary Wakefield.

The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.

The update aims to help the public better protect themselves and understand their risk.

“We urge the Senate and House to consider the nation’s…research and prevention needs and allocate maximum medical research funding.”

World Hepatitis Day aims to eliminate viral hepatitis by 2030 by spreading awareness and combating stigma surrounding the disease.

Maintaining a healthy body weight, being physically active and following a healthy diet are linked to improved survival.